Peter L Roberson Selected Research

4- aminophenylethyl- 1,4,7,10- tetraazacyclodecane- N,N',N'',N'''- tetraacetic acid

4/2003

Three-dimensional dose model for the comparison of 177Lu-HuCC49DeltaCH2 and 177Lu-HuCC49 radioimunotherapy in mice bearing intraperitoneal xenografts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter L Roberson Research Topics

Disease

9	Neoplasms (Cancer) 11/2018 - 04/2003
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2017 - 04/2010
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2006
1	Prostatic Neoplasms (Prostate Cancer) 01/2005
1	Erectile Dysfunction 01/2005

Drug/Important Bio-Agent (IBA)

6	Biological ProductsIBA 01/2020 - 05/2011
2	tositumomab I-131 (Bexxar)FDA Link 07/2010 - 04/2010
2	Monoclonal AntibodiesIBA 10/2005 - 04/2003
1	Biomarkers (Surrogate Marker)IBA 11/2017
1	Protons (Proton)IBA 05/2011
1	Radioisotopes (Radionuclides)IBA 07/2010
1	tumor-associated antigen 72IBA 10/2005
1	AntibodiesIBA 10/2005
1	Chelating AgentsIBA 04/2003
1	4- aminophenylethyl- 1,4,7,10- tetraazacyclodecane- N,N',N'',N'''- tetraacetic acidIBA 04/2003

Therapy/Procedure

8	Therapeutics 11/2018 - 01/2006
5	Radioimmunotherapy 11/2017 - 07/2010
2	Microspheres (Microsphere) 01/2020 - 11/2018
2	Injections 02/2014 - 05/2011
1	Radiotherapy 01/2005
1	Brachytherapy 01/2005